Using Genetics to Target Cancer's Achilles' Heel

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/169144847/169144836" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Guests

John DiPersio, Chief, Division of Oncology, Washington University School of Medicine, Barnes-Jewish Hospital Deputy Director, Siteman Cancer Center, St. Louis, Missouri

Gary Gilliland, Senior Vice President and Global Head of Oncology, Merck & Co., North Wales, Pennsylvania

To develop more effective treatments for cancer, doctors are zeroing in on the disease's genetic drivers. John DiPersio, chief of oncology at Washington University Medical Center, and Merck's Gary Gilliland discuss how this may revolutionize the future of cancer treatment.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.